Study guide

2.5 Assessment of Co-Occurring Psychiatric & Medical Disorders

Certified Addictions Registered Nurse CARN

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Exam Overview

1.1 CARN Exam Overview, Eligibility & Requirements 1.2 How to Use This Study Guide & Preparation Strategy

2 Chapter 2: Assessment & Screening

2.1 DSM-5-TR Substance Use Disorder Diagnostic Criteria & Severity Classification 2.2 Standardized Screening Tools: AUDIT, DAST-10, CAGE, CRAFFT & ASSIST 2.3 Withdrawal Severity Rating Scales: CIWA-Ar & COWS 2.4 Neonatal & Special Population Assessment: Finnegan, Eat-Sleep-Console & Life Stages 2.5 Assessment of Co-Occurring Psychiatric & Medical Disorders

3 Chapter 3: Planning & Intervention

3.1 ASAM Criteria & Continuum of Placement Care 3.2 Motivational Interviewing (OARS) & Transtheoretical Stages of Change 3.3 Trauma-Informed Care Principles & Addictions Nursing Practice 3.4 Family Dynamics, Codependency, CRAFT Model & Family Support Systems 3.5 Nursing Diagnosis, Outcome Identification & Individualized Addictions Care Planning

4 Chapter 4: Clinical Management & Pharmacotherapy

4.1 Alcohol Withdrawal Syndrome Management & Complication Prevention 4.2 Opioid Withdrawal Management & Symptom-Triggered Protocols 4.3 Medications for Opioid Use Disorder (MOUD: Methadone, Buprenorphine & Extended-Release Naltrexone) 4.4 Pharmacotherapy for Alcohol & Nicotine Use Disorders 4.5 Harm Reduction Strategies: Naloxone, Fentanyl Test Strips & Syringe Services 4.6 Pain Management in Patients with Substance Use Disorders

5 Chapter 5: Substance-Specific Disorders, Prevention & Patient Education

5.1 Stimulant Use Disorders: Cocaine, Amphetamines & Caffeine 5.2 Sedative, Hypnotic, Anxiolytic & Gabapentinoid Misuse 5.3 Cannabis & Hallucinogen Use Disorders 5.4 Tobacco Use Disorder, Vaping & Cessation Interventions 5.5 Prevention, Brief Intervention, Patient Education & Behavioral Addictions

6 Chapter 6: Evaluation, Recovery & Continuing Care

6.1 Relapse Prevention Models: Marlatt's Model, Urge Surfing & High-Risk Situations 6.2 Mutual-Help Groups & Peer Recovery Support: 12-Step, SMART Recovery & Peer Specialists 6.3 Recovery Capital, Social Determinants of Health & Holistic Wellness 6.4 Transitions of Care, Discharge Planning & Long-Term Recovery Management

7 Chapter 7: Professional Role, Ethics & Legal Issues

7.1 ANA/IntNSA Scope & Standards of Addictions Nursing Practice 7.2 Confidentiality Laws: 42 CFR Part 2 vs. HIPAA & 2024 Alignment Updates 7.3 Legal & Ethical Issues, Stigma Reduction & Person-First Language

2.5 Assessment of Co-Occurring Psychiatric & Medical Disorders

Key Takeaways Explain This Topic AI

Co-occurring disorders (dual diagnosis) affect >50% of individuals with severe SUDs, requiring integrated simultaneous assessment rather than outdated sequential treatment models.

Differentiating primary psychiatric disorders from substance-induced psychiatric conditions requires evaluating symptom persistence during a period of sustained abstinence (typically ≥4 weeks).

Wernicke's Encephalopathy presents with the classic triad of encephalopathy, ataxia, and oculomotor dysfunction; immediate high-dose intravenous thiamine MUST precede glucose administration to prevent irreversible Korsakoff psychosis.

Injection drug use (IDU) carries high risk for severe medical comorbidities including Infective Endocarditis (Staphylococcus aureus affecting the tricuspid valve), Hepatitis C Virus (HCV), HIV, and spinal epidural abscess.

Comprehensive laboratory assessment for SUD patients includes liver function tests (AST/ALT ratio >2:1 suggestive of alcoholic liver disease), CBC (macrocytic anemia/thrombocytopenia), infectious disease panels, and urine drug testing (UDT).

Last updated: August 2026

  • Assessment of Co-Occurring Psychiatric & Medical Disorders
  • Principles of Dual Diagnosis Assessment

The co-occurrence of a Substance Use Disorder (SUD) alongside one or more mental health conditions—commonly referred to as Dual Diagnosis or Co-Occurring Disorders (COD) —is the rule rather than the exception in clinical addiction practice. Epidemiological data indicate that over 50% of individuals seeking treatment for severe substance use disorders meet diagnostic criteria for a co-occurring psychiatric condition, such as Major Depressive Disorder, Bipolar I Disorder, Post-Traumatic Stress Disorder (PTSD), Generalized Anxiety Disorder, or Schizophrenia.

Historically, healthcare systems operated under a sequential model (treating addiction first, then mental health, or vice versa). Modern evidence-based nursing practice enforces an Integrated Assessment and Treatment Model , where both psychiatric and substance use conditions are assessed and treated simultaneously by a unified care team.

Primary vs. Substance-Induced Psychiatric Disorders

A critical diagnostic challenge for the CARN nurse is distinguishing between a primary psychiatric disorder and a substance-induced psychiatric disorder . Substance intoxication and withdrawal can mimic virtually every psychiatric condition (e.g., stimulant-induced psychosis mimicking paranoid schizophrenia, or alcohol withdrawal-induced anxiety mimicking panic disorder).

Diagnostic Differentiation Matrix

Assessment Parameter Primary Psychiatric Disorder Substance-Induced Disorder

Onset Relative to Use Symptoms precede the onset of substance use or persist long after. Symptoms develop during or within 1 month of acute intoxication or withdrawal.

Persistence During Abstinence Symptoms persist for >4 weeks following documented complete abstinence. Symptoms resolve rapidly as substance clears (typically within days to <4 weeks).

Substance Specificity Symptoms are inconsistent with the known pharmacological effects of the used drug. Symptoms closely match known drug effects (e.g., amphetamine paranoia, alcohol depression).

Personal / Family History Strong family history of primary psychiatric illness (e.g., Bipolar, Schizophrenia). Family history prominent for SUD; psychiatric symptoms fluctuate directly with drug supply.

CARN Clinical Benchmark: To definitively establish a primary psychiatric diagnosis, guidelines recommend observing the patient during a period of at least 4 weeks of verified abstinence , unless psychiatric symptoms clearly predated the onset of substance use.

Physical Health Assessment & High-Risk Medical Comorbidities

Substance misuse inflicts severe multiorgan toxicity. Addictions nurses must conduct targeted physical assessments to detect life-threatening medical comorbidities early.

Cardiac & Infectious Complications of Injection Drug Use (IDU)

Infective Endocarditis (IE): Intravenous drug use introduces skin flora directly into venous circulation, commonly causing Staphylococcus aureus endocarditis. The tricuspid valve is affected in >75% of IDU cases. Clinical signs include high fever, new heart murmur, Janeway lesions (painless erythematous macules on palms/soles), Osler nodes (painful subcutaneous nodules on pads of digits), and pulmonary septic emboli.

Blood-Borne Pathogens: Universal screening for Hepatitis C Virus (HCV) , Hepatitis B Virus (HBV) , and HIV is mandatory for all SUD patients. HCV antibody testing with reflex RNA PCR confirms active infection.

Spinal Epidural Abscess / Osteomyelitis: IDU patients presenting with localized severe back pain, fever, and neurological deficits require immediate MRI evaluation for spinal infection.

Hepatic & Gastrointestinal Pathology

Alcoholic Liver Disease: Chronic alcohol misuse causes steatohepatitis, cirrhosis, portal hypertension, esophageal varices, and hepatic encephalopathy.

Pancreatitis: Severe epigastric pain radiating to the back, accompanied by elevated serum lipase and amylase.

Neurological Emergency: Wernicke-Korsakoff Syndrome

Wernicke's Encephalopathy (WE) is an acute, life-threatening neurological emergency caused by severe thiamine (Vitamin B1) deficiency , most commonly resulting from chronic alcohol misuse, poor nutritional intake, and impaired intestinal thiamine absorption.

The Classic Clinical Triad of Wernicke's Encephalopathy

Encephalopathy: Confusion, disorientation, apathy, and altered sensorium.

Ataxia: Gait instability and uncoordinated trunk movement.

Oculomotor Dysfunction: Horizontal/vertical nystagmus, lateral rectus palsy, and conjugate gaze ophthalmoplegia.

CRITICAL CARN SAFETY RULE: If Wernicke's Encephalopathy is suspected, high-dose intravenous thiamine (500 mg IV TID for 3–5 days) MUST be administered BEFORE or concurrently with any intravenous dextrose/glucose solutions. Administering glucose prior to thiamine precipitates acute thiamine exhaustion during glycolysis, triggering irreversible brainstem necrosis and progression to permanent Korsakoff Psychosis (characterized by severe anterograde/retrograde amnesia and confabulation).

Comprehensive Laboratory & Diagnostic Testing Workup

A complete laboratory assessment provides objective data regarding organ function, nutritional status, and active substance exposure.

Laboratory Diagnostic Panel Key Evaluated Parameters Clinical Significance for Addiction Nursing

Hepatic Function Panel AST, ALT, Total Bilirubin, Alkaline Phosphatase An AST to ALT ratio > 2:1 is strongly characteristic of alcoholic liver disease.

Complete Blood Count (CBC) Macrocytic MCV (>100 fL), Platelets, WBC Elevated Mean Corpuscular Volume (MCV) indicates chronic alcohol exposure or folate/B12 deficiency. Thrombocytopenia indicates portal hypertension/splenomegaly.

Pancreatic Enzymes Serum Lipase, Amylase Lipase >3x upper limit of normal confirms acute alcohol-induced pancreatitis.

Nutritional Markers Thiamine, Folate, Vitamin B12, Magnesium, Phosphate Hypomagnesemia and hypophosphatemia increase risk for withdrawal seizures and cardiac arrhythmias.

Urine Drug Testing (UDT) Immunoassay Screen + Gas Chromatography / Mass Spectrometry (GC/MS) confirmation Evaluates recent substance ingestion (e.g., opioids, cocaine, benzodiazepines, amphetamines, cannabis, fentanyl).

Infectious Serologies HIV 1/2 Ag/Ab, HCV Ab w/ reflex RNA, HBsAg, RPR/Treponemal Baseline screening for blood-borne and sexually transmitted infections.

Clinical Prevalence & Diagnostic Differentiation of Dual Diagnosis